NM_001495.5(GFRA2):c.725C>T (p.Ser242Phe) AND Pazopanib response
- Germline classification:
- drug response (1 submission)
- Last evaluated:
- Jul 16, 2015
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000190397.2
Allele description [Variation Report for NM_001495.5(GFRA2):c.725C>T (p.Ser242Phe)]
NM_001495.5(GFRA2):c.725C>T (p.Ser242Phe)
Condition(s)
- Name:
- Pazopanib response
- Identifiers:
- MedGen: CN232333
Assertion and evidence details
Last Updated: Apr 23, 2022